BRCA2 and neoplasm: The graph highlights key influential papers, such as the one published in Nature titled “Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy” by Farmer et al. (2005), which has the highest citation of 276, and the study in Nature titled “Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase” by Bryant et al. (2005) which has the citation of 248.